Karyopharm Therapeutics Inc. Financial Ratios — 25K0 Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-41.9	-58.34	-60.77	-88.43	-114.13	-171.36	-391.29	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-372.3	-42.56	-40.03	-54.24	-55.37	-71.52	-68.42	-62.75	-64.56	-40.13	-49.83	-47.81	-37.75	-143.71
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	100	94.11	97.5	98.38	96.68	96.62	95.86	95.93
EBITDA Margin (%)	-6,728.95	-2,487.07	-8,735.4	-32,979.48	-47,376.8	-71,438.31	-8,088.79	-590.55	-460.47	-158.1	-46.46	-90.14	-88.34	-82.01	-61.9
Operating Margin (%)	-6,783.55	-2,506.31	-8,772.61	-33,120.52	-47,630.4	-71,903.9	-8,133.21	-592.97	-462.85	-159	-46.84	-90.53	-88.71	-82.24	-62.1
Incremental Operating Margin (%)	- -	- -	7,311.74	26,516.46	- -	- -	- -	- -	- -	25.93	72.32	83.29	- -	- -	3,462.17
Pretax Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,063.64	-8,032.46	-588.02	-487.98	-181.31	-59.01	-105	-97.77	-52.58	-134.18
Profit Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,153.9	-8,036.39	-588.1	-488.08	-181.59	-59.14	-105.23	-97.99	-52.62	-134.21
Net Income to Common Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,153.9	-8,036.39	-588.1	-488.08	-181.59	-59.14	-105.23	-97.99	-52.62	-134.21
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-41.9	-58.34	-60.77	-88.43	-114.13	-171.36	-391.29	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	103	125	131	181	179	177	195	234
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	3	3	25	22
LT Debt	- -	- -	- -	- -	- -	- -	- -	103	123	129	178	176	174	170	212
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.66	-0.77	-1.85	-1.26	-1.37	-1.63	-2.58
Net Debt/EBITDA	0.64	0.02	4.61	1.99	0.49	0.45	0.53	0.09	0.1	-0.19	0.22	-0.25	-0.92	-1.05	-1.84
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.66	-0.76	-1.84	-1.26	-1.37	-1.63	-2.58
Net Debt/EBIT	0.63	0.02	4.59	1.99	0.49	0.45	0.53	0.09	0.1	-0.19	0.22	-0.25	-0.92	-1.05	-1.83
EBITDA to Interest Expense	- -	- -	- -	-75,523	- -	- -	- -	-71.86	-12.03	-6.3	-3.74	-5.66	-5.42	-3.18	-1.97
EBITDA-CapEx/Interest Expense	- -	- -	- -	-78,357	- -	- -	- -	-72.81	-12.05	-6.3	-3.96	-5.67	-5.42	-3.19	-1.97
EBIT to Interest Expense	- -	- -	- -	-75,846	- -	- -	- -	-72.16	-12.1	-6.33	-3.77	-5.69	-5.44	-3.19	-1.98
Interest Expense	- -	- -	- -	- -	- -	- -	- -	2	16	27	26	25	24	37	46
Common Equity/Total Assets	-175.12	-2,126.39	97.92	93.85	92.07	89.94	71.81	53.69	16.87	16.15	-26.1	-4.65	-56.65	-113.14	-270.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	247.24	255.63	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	70.53	71.12	176.66	108.49	425.65	1,994.36	-356.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	41.72	41.28	58.39	49.19	72.25	103.19	195.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	250.54	259.43	-226.65	-1,075.13	-129.96	-104.57	-79.75
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	71.47	72.18	178.96	110.26	433.76	2,286.63	-393.81
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	42.28	41.89	59.15	50	73.62	118.31	215.47
Net Debt to Equity	51.47	1.4	-100.67	-72.83	-29.42	-30.61	-53.29	-8.38	-38.17	63.33	26.57	-209.64	-87.14	-67.14	-56.79
Net Debt/Capital (%)	33.98	1.38	14,997.5	-268.06	-41.68	-44.11	-114.11	-9.15	-41.65	33.43	23.63	128.23	-1,039.21	-231.43	-138.79
EBITDA	-10	-16	-34	-76	-118	-110	-130	-179	-188	-171	-97	-142	-129	-119	-90
EBITDA-CapEx	-11	-16	-34	-78	-120	-110	-130	-182	-189	-171	-103	-142	-129	-119	-90
Operating Income (Loss)	-10	-16	-34	-76	-119	-111	-131	-180	-189	-172	-98	-142	-130	-119	-91

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.08	0.2	47.38	16.72	11.61	7.86	2.96	7	5.65	4.14	3.1	4.22	2.76	1.18	0.69
Current Ratio	3.24	0.49	47.98	16.89	11.74	7.99	3	7.13	6.01	4.59	3.74	5.31	3.37	1.7	1.12
Quick Ratio	3.08	0.2	47.38	16.72	11.61	7.86	2.96	7	5.82	4.35	3.41	4.93	3.14	1.51	0.98
CFO/Avg Current Liab	- -	-7.66	-11.6	-6.6	-6.86	-5.34	-2.24	-3.3	-4.09	-3.01	-1.6	-2.14	-1.37	-1.58	-0.82
Common Equity/Total Assets	-175.12	-2,126.39	97.92	93.85	92.07	89.94	71.81	53.69	16.87	16.15	-26.1	-4.65	-56.65	-113.14	-270.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	247.24	255.63	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	70.53	71.12	176.66	108.49	425.65	1,994.36	-356.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	41.72	41.28	58.39	49.19	72.25	103.19	195.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	250.54	259.43	-226.65	-1,075.13	-129.96	-104.57	-79.75
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	71.47	72.18	178.96	110.26	433.76	2,286.63	-393.81
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	42.28	41.89	59.15	50	73.62	118.31	215.47
CFO/Total Liabilities	-43.01	-53.13	-920.11	-379.88	-550.59	-465.17	-145.03	-100.69	-77.83	-61.04	-27.82	-39.9	-24.62	-36.38	-18.78
CFO/CapEx	-22.74	-128.17	-531.4	-18.15	-66.4	-1,205.59	-1,188.98	-67.34	-926.32	-1,105.06	-18.75	-1,267.41	- -	-897.79	- -
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	10.4	10.42	11.86	4.51	3.94	5.03	5.13
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	35.09	35.02	30.77	80.85	92.54	72.54	71.15
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	13.91	1.81	1.01	1.25	1.36	1.54	1.36
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	26.23	201.73	362.1	291.62	268.36	236.43	269.26
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	1.04	1.84	1.61	2.44	1.28	1.87	1.15
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	352.47	198.26	227.11	149.81	286.1	194.99	316.8
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-291.15	38.49	165.76	222.66	74.8	113.98	23.6
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	8.85	-166.7	-331.33	-210.78	-175.82	-163.89	-198.11
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4	4	3	5	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	2	4	3
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	7	- -	156	151	58	50	69	118	129	86	190	135	52	62	61
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	103	125	131	181	179	177	195	234
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Capital	-13	-28	155	207	198	162	129	286	174	182	101	162	41	9	-59
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	71.47	72.18	178.96	110.26	433.76	2,286.63	-393.81
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	1	- -	- -	- -	- -	2	30	41	108	210	157	146	145	146
TTM EBITDA	-10	-16	-34	-76	-118	-110	-130	-179	-188	-171	-97	-142	-129	-119	-90
TTM Operating Income	-10	-16	-34	-76	-119	-111	-131	-180	-189	-172	-98	-142	-130	-119	-91
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

No data availableFinancial data will appear here once available

Per Share Data Items (USD)

Per-Share Data API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Shares Outstanding	2	2	2	2	2	3	3	4	4	5	5	8	8	8	18
Diluted Weighted Avg Shares	1	1	- -	2	2	3	3	4	4	5	5	5	8	8	11
Basic Weighted Avg Shares	1	1	- -	2	2	3	3	4	4	5	5	5	8	8	11
Revenue per Share	0.23	0.97	0.96	0.11	0.11	0.06	0.52	8.01	9.9	22.5	41.84	28.78	19.17	17.88	13.36
EBITDA per Share	-15.66	-24.14	-83.57	-36.38	-49.88	-43.98	-42.43	-47.31	-45.59	-35.58	-19.44	-25.94	-16.94	-14.66	-8.27
Operating Income per Share	-15.79	-24.33	-83.93	-36.54	-50.15	-44.27	-42.66	-47.5	-45.83	-35.78	-19.6	-26.05	-17.01	-14.7	-8.3
Basic EPS, GAAP	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.41	-17.93
Basic EPS from Cont Ops	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.41	-17.93
Diluted EPS, GAAP	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.04	-17.93
Diluted EPS from Cont Ops	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.04	-17.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-13.09	-23.75	-74.88	-24.79	-39.6	-33.74	-24.09	-42.02	-46.2	-33.36	-21.36	-27.4	-12.17	-15.69	-6.89
Free Cash Flow per Basic Share	-13.66	-23.93	-75.02	-26.15	-40.19	-33.76	-24.11	-42.64	-46.25	-33.39	-22.5	-27.42	-12.17	-15.71	-6.89
Cash & Equivalents per Share	3.4	0.2	79.07	94.37	73.46	46.39	44.35	80.93	60.11	50.57	45.27	36.83	24.99	12.92	3.48
Book Value per Share	-6.61	-14.55	78.55	94.86	82.96	58.1	39.21	45.17	11.42	10.26	-15.78	-2.21	-17.78	-22.11	-16
Tangible Book Value per Share	-6.61	-14.55	78.55	94.86	82.96	58.1	39.21	45.17	11.42	10.26	-15.78	-2.21	-17.78	-22.11	-16